1. NF-κB
    Apoptosis
  2. NF-κB
    Apoptosis
  3. SP-8356

SP-8356 

Cat. No.: HY-130234 Purity: 99.11%
Handling Instructions

SP-8356, an anti-inflammatory synthetic Verbenone derivative, is a potent, orally active cluster of differentiation 147 (CD147) inhibitor. SP-8356 inhibits CD147-cyclophilin A (CypA) interaction and reduces MMP-9 activity. SP-8356 exerts anti-breast cancer effects by inhibiting NF-κB signaling. Anti-atherosclerotic effects.

For research use only. We do not sell to patients.

SP-8356 Chemical Structure

SP-8356 Chemical Structure

CAS No. : 1454885-45-0

Size Price Stock Quantity
5 mg USD 420 In-stock
Estimated Time of Arrival: December 31
10 mg USD 700 In-stock
Estimated Time of Arrival: December 31
50 mg USD 1900 In-stock
Estimated Time of Arrival: December 31
100 mg USD 3000 In-stock
Estimated Time of Arrival: December 31
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

Customer Review

Based on 1 publication(s) in Google Scholar

Top Publications Citing Use of Products

View All NF-κB Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

SP-8356, an anti-inflammatory synthetic Verbenone derivative, is a potent, orally active cluster of differentiation 147 (CD147) inhibitor. SP-8356 inhibits CD147-cyclophilin A (CypA) interaction and reduces MMP-9 activity. SP-8356 exerts anti-breast cancer effects by inhibiting NF-κB signaling. Anti-atherosclerotic effects[1][2][3].

In Vitro

SP-8356 (5-10 μM; 48 hours) inhibits growth of various types of breast cancer cell lines in a time- and dose-dependent manner[1].
SP-8356 (10 μM; 48 hours) increases percentage of MDA-MB231 cells in S phase and decreases casapas-3 and cleaved PARP[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay[1]

Cell Line: MDA-MB231, MDA-MB453, 4T1, and MCF-7 cells
Concentration: 5, 10 μM
Incubation Time: 48 hours
Result: Inhibited growth of various types of breast cancer cell lines in a time- and dose-dependent manner.

Cell Cycle Analysis[1]

Cell Line: MDA-MB231 cells
Concentration: 1, 5, 10 μM
Incubation Time: 48 hours
Result: Increased percentage of MDA-MB231 cells in S phase at 10 μM.

Western Blot Analysis[1]

Cell Line: MDA-MB231 cells
Concentration: 10 μM
Incubation Time: 48 hours
Result: Decrease of casapas-3 and cleaved PARP were observed.
In Vivo

SP-8356 (10 mg/kg; i.p.; every three days until the 42nd day) inhibits tumor growth in a xenograft mouse model[1].
SP-8356 (50 mg/kg; p.o.; daily one day after carotid artery ligation for three weeks) prevents the formation of plaque and attenuates its vulnerability[2].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Five-week-old female NOD/SCID mice (MDA-MB231 xenografts)[1]
Dosage: 10 mg/kg
Administration: I.p.; every three days until the 42nd day
Result: The tumor volumes of mice were significantly lower.
Animal Model: Male ApoE KO mice (7 weeks old, 20 g body weight)[2]
Dosage: 50 mg/kg
Administration: P.o.; daily one day after carotid artery ligation for three weeks
Result: Induced a significant reduction in plaque size and plaque/media ratiowith decreased lipid and necrotic core areas.
Molecular Weight

300.35

Formula

C₁₈H₂₀O₄

CAS No.

1454885-45-0

SMILES

O=C1[[email protected]](C2)([H])C(C)(C)[[email protected]]2([H])C(/C=C/C3=CC(OC)=C(O)C(O)=C3)=C1

Shipping

Room temperature in continental US; may vary elsewhere.

Storage
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
Solvent & Solubility
In Vitro: 

DMSO : 100 mg/mL (332.94 mM; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 3.3294 mL 16.6472 mL 33.2945 mL
5 mM 0.6659 mL 3.3294 mL 6.6589 mL
10 mM 0.3329 mL 1.6647 mL 3.3294 mL
*Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: 2.5 mg/mL (8.32 mM); Clear solution; Need ultrasonic

  • 2.

    Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.5 mg/mL (8.32 mM); Clear solution

*All of the co-solvents are provided by MCE.
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2

Keywords:

SP-8356SP8356SP 8356NF-κBApoptosisNuclear factor-κBNuclear factor-kappaBtriple-negativebreastcancercellsTNBCmetastasisplaqueprogressionatheroscleroticMMP-9Inhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email address *

Phone number *

 

Organization name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
SP-8356
Cat. No.:
HY-130234
Quantity:
MCE Japan Authorized Agent: